Celltext™ products are less invasive than adipose tissue extraction and bone marrow aspiration resulting in less time-consuming procedures, and more importantly less pain.
Celltext™ does not use any material obtained directly from the embryo or fetus. Celltext™ has higher concentrations of peptides, hyaluronic acid and growth factors when compared to amniotic fluid suspensions. Due to high concentrations of growth factors in the Umbilical Cord Matrix, also known as Wharton’s Jelly, it acts as an ideal anti-inflammatory and has been shown in clinical studies to prevent apoptosis.
Celltext™ is processed from human tissue, donated following full term, c-section deliveries, in accordance with the FDA.
Celltext™ is regulated as a human cell, tissue or cellular tissue-based product (HCT/P) under 21 CFR Part 1271 and Section 361 of the Public Health Service Act.